Working in close partnership with patients, scientists at the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In have identified new causes of a rare cancer of blood ...
Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion. Receiving a diagnosis of breast angiosarcoma can ...
Angiosarcoma is a rare and highly aggressive malignancy arising from the endothelial lining of blood or lymphatic vessels. It most commonly affects skin, breast, liver and deep soft tissues and is ...
After radiotherapy for breast cancer, approximately one in 1000 women will go on to develop radiotherapy-associated angiosarcoma (RAAS), and surgery alone is sufficient to treat the disease in most ...
Background A 37-year-old man presented with a history of hemoptysis and associated fever, chills, night sweats, and weight loss. The patient had no other pertinent past medical history. Investigations ...
Extra-gastrointestinal stromal tumors (eGISTs): Experience of a cooperative group. A phase I/II study of azacitidine in combination with temozolomide in patients with unresectable or metastatic soft ...
“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...
“Novel approaches to immunotherapy, targeted therapy and combinations with standard chemotherapy are all areas of current research interest,” says an expert at Dana-Farber Cancer Institute Sarcoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results